title: Age-related macular degeneration, anti-VEGF therapy, and ophthalmic imaging: is there a best practice?
authors.affiliation: Medical College of Wisconsin, Milwaukee.
authors.forename: Dennis P
authors.initials: DP
authors.lastname: Han
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000191:economics; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000191:economics; D000068258:Bevacizumab; D016527:Drug Costs; D006801:Humans; D017410:Practice Guidelines as Topic; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D057135:Wet Macular Degeneration / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab